# US 2012/0251440 A1 · Methods of myocardial perfusion imaging

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0251440 A1
- Document ID: US20120251440A1
- Status: Published application
- Kind: A1
- Application number: 13/525,223
- Filed: 2012-06-15
- Published: 2012-10-04
- Earliest claimed: 2000-02-23
- Assignees: Gilead Sciences, Inc.
- Inventors: Luiz Belardinelli; Brent K. Blackburn; Zhenhai Gao
- Web page: https://patentgrep.com/patent/US20120251440A1

## CPC

- C07H 19/16: Purine radicals
- A61K 51/00: Preparations containing radioactive substances for use in therapy or testing in vivo
- A61P 9/08: Vasodilators for multiple indications
- G01N 33/5008: {for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics}
- G01N 33/502: {for testing non-proliferative effects}
- G01N 33/5082: {Supracellular entities, e.g. tissue, organisms}
- G01N 33/5088: {of vertebrates}
- G01N 33/566: using specific carrier or receptor proteins as ligand binding reagents {where possible specific carrier or receptor proteins are classified with their target compounds}
- G01N 2500/04: Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention provides a method for identifying and using partial adenosine A2A receptor agonists that are useful as adjuncts in myocardiological perfusion imaging.

## Claims

### Claim at position 1

1-14. (canceled)

### Claim 15

A method of myocardial perfusion imaging in a human in need thereof comprising: administering to the human (a) CVT-3146, also known as (1-{9-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-N-methylcarboxamide, in an amount of 0.2 to 9 μg/kg by a single intravenous bolus dose of a liquid pharmaceutical composition comprising CVT-3146 and (b) a radionuclide, and thereafter determining areas of insufficient blood flow.

### Claim 16 (depends on 15)

The method of claim 15, wherein the amount of CVT-3146 administered is 1 to 9 μg/kg.

### Claim 17 (depends on 15)

The method of claim 15, wherein the pharmaceutical composition is administered before the radionuclide is administered.
